Health and life sciences

Australia is a growing exporter of niche life sciences services, medical products and medtech. Our advanced clinical trials networks are used by global pharmaceutical companies.

• Australian clinical trials data is accepted by global regulators, including the US Food and Drug Administration, and the European Medicines Agency.
• Over 750 organisations support life science research development, commercialisation and manufacturing. 
• Exports include bionic devices, implants, nanotechnology and 3D-printed body parts.

Digital goods include smart devices, wearable devices and digital therapeutics.

Australia’s medical technology sector is a critical pillar of the nation’s health system, advanced manufacturing capability and export economy.

The Medical Technology, Devices and Diagnostics Industry Capability Report, co-authored by the Medical Technology Association of Australia (MTAA) and Austrade, provides a comprehensive overview of Australia’s MedTech strengths and global competitiveness.

Australian MedTech supports the prevention, diagnosis, treatment and management of disease and disability through a diverse range of technologies, from implantable devices and diagnostics to robotics, precision engineering and software-based solutions including artificial intelligence and digital health.

This report positions Australia as a trusted, innovation-driven MedTech partner and reinforces the country’s role as a strategic gateway into fast-growing healthcare markets across the Asia-Pacific and GCC regions, as well as established North American and European markets.

Australia’s advanced digital health sector has the proven capability and readiness to deliver scalable, secure, and effective healthcare solutions for markets worldwide.

Australia is underpinned by world-class innovation, strong government support, and robust standards for interoperability.

With a National Digital Health Strategy ranked #1 globally, Australia offers a vibrant ecosystem delivering innovative solutions to complex healthcare needs around the world

The Australian Digital and Connected Health Industry Report, developed in collaboration with ANDHealth and Austrade, showcases Australia is a world-leader in national digital health infrastructure with a proven track record in digital health innovation.

Australia’s thriving and integrated life science ecosystem holds a distinct and critical position within the global landscape, due to its strength, innovation and strategic connectivity to the Asia Pacific region.

As the world’s largest island nation with seven states and two territories, Australia is a stable economic and regulatory hub connecting world class standards to regional markets.

Australia offers unique competitive advantages that make it an attractive, low-risk destination for collaboration and long-term strategic partnerships.

The Life Sciences in Australia industry capability report, developed in collaboration with AusBiotech and Austrade, features Australia is a reliable, productive, and sophisticated partner that excels across the entire life sciences value chain—from research and discovery to commercialisation and manufacturing.

The Government wants Australia to be a global leader in life sciences. This includes research, trials, commercialisation, manufacturing and exporting.

• Australia's A$20 billion  MRFF aims to transform health and medical research, and innovation.
• We consistently rank among Nature Index’s top 10 contributors to life sciences research globally – including 8^th in 2023.
• Our advantages include high-quality infrastructure, streamlined regulatory pathways, an ethnically diverse population, high quality regulators and globally recognised clinicians.
• Australia ranks 3rd for intellectual property rights in the region on the International Property Rights Index 2022.

Australia’s life sciences sector benefits from a strong but flexible regulatory regime. Our business culture promotes R&D and commercialisation. 

Australia has a rich network of life sciences organisations. These includes research institutes and capabilities, health precincts, national industry bodies that draw the industry together, initiatives and funding for innovation collaboration, and accelerator programs. 

• Health is one of the top 6 priority areas for Australia’s national science agency, the Commonwealth Scientific and Industrial Research Organisation (CSIRO). Areas of expertise include molecular diagnostic solutions and precision health. (Source: CSIRO Annual Report 2022-23).
• Our health precincts connect hospitals, universities, research institutes and industry partners. The Melbourne Biomedical Precinct is one of the largest precincts in the Southern Hemisphere.
• AusBiotech maintains a database on Australian Life Sciences Incubator and Accelerator Programmes.
• Cooperative Research Centre (CRC) programs – such as the Digital Health CRC – maximise translational research by working with the private sector.
• The Digital Health Blueprint outlines Australia’s 10-year vision for digital health. 

CSIRO facilities include the National Vaccine and Therapeutics Lab; the Recombinant Protein Production and Purification Facility; the Australian Centre for Disease Preparedness; and the Biomedical Materials Translational Facility.